(29 August 2018 – Hong Kong) The United Laboratories International Holdings Limited (「TUL」, the 「Company」 or the 「Group」; Stock code: 3933), one of the leading pharmaceutical product manufacturers in the PRC, ann...

On August 4, 2018, the (35th) annual conference of Chinese pharmaceutical industry held in Shanghai.Theconferencereleased TOP 100 enterprises of China's pharmaceutical industry in 2017. Zhuhai United Laboratories Co., L...

Recently, amoxicillin capsule (0.25g) produced by TUL was approved by China Food and Drug Administration, passed the consistency of quality and efficacy evaluation for generic drugs (the 「Consistency Evaluation」).

After Shen Zhulin, deputy director of NDRC High-tech Industry Division together with his fellows paid a visit on July 5, a 13-member delegation led by Liao Bing, Party Committee Secretary of Guangdong Academy of Science...

United Lab launched a campaign to care for orphaned/disabled children themed on 「United Lab, United Love for Children」, calling for its employees to make financial or material donations for children in Zhuhai Social W...

The 「Summit of Basal Insulin』s Clinical Application」 sponsored by Chinese Journal of Diabetes Mellitus was held at Chimelong Hengqin Bay Hotel on May 13, and presided over by Weng Jianping, editor in chief of Chinese...